Singapore Dialysis
Concentrate Industry:
The rise in the geriatric
population and increase in kidney disorders have increased the need for
dialysis across the globe. Dialysis performs the function of the kidney in
cases of kidney failure. The treatment purifies the blood using the dialysis
machine and aids the patient in maintaining the balance between fluid and
electrolytes in the body. For this treatment, various apparatuses are used including
dialysis concentrate, dialysis catheter, dialysis disinfectant, and other
dialysis products.
What Is Singapore Dialysis Concentrate?
Dialysis concentrate consists
of purified water, electrolytes, and glucose. The concentration of the electrolytes
is almost similar to that occurs naturally in the blood. The dialysis
concentrate is carefully prepared as per the individual’s requirement to help
regulate the acid-base balance and electrolyte, which could remove metabolic
waste from the body.
Dialysis concentrate is
Hamodialysis contains a solution of pure water, bicarbonate, sodium, and
electrolytes. The solution pulls toxins from the patient’s blood into the
dialysate and the dialysis solution is flushed down the drain.
According to Allied
Market Research, the global dialysis concentrate market is expected to reach $4.53 billion by 2030,
growing at a CAGR of 5.4% from 2021 to 2030. Rise in incidences of kidney
diseases, surge in prevalence of lifestyle and chronic diseases, and issues
associated with kidney transplants have boosted the growth of the market.
Impact of COVID-19 Pandemic on Singapore Dialysis Concentrate Market (Pre & Post Analysis)
However, in 2020, the outbreak of the COVID-19 pandemic led to have a
negative impact on the growth of the dialysis concentrate market, especially in
the initial period. The implementation of global lockdown restricted the
functioning hours of all endoscopy procedures across the world. In order to
maintain the social distancing norms, most of the departments in the hospitals
were closed and few of them were opened with limited staff. Nevertheless, the
global dialysis concentrate market is going to get back on track with a steady
pace, once the lockdown is completely over.
Request for Sample Report for More Insights@ https://www.alliedmarketresearch.com/request-sample/14054
Top Leading Players:
·
Asahi Kasei
Medical Co. Ltd
·
B. Braun
Melsungen AG
·
Baxter
International Inc.
·
Dialysis Medical
Solutions
·
Farmasol
·
Fresenius Medical
Care
·
Hemoclean
Advent Of New Methods For Better Dialysis
Over the years, the
effectiveness of dialysis has increased significantly with the advancements in
blood thinners and medical apparatus. However, the researchers have found a way
to eliminate the use of blood thinners in patients on dialysis.
Currently, anticoagulation
is necessary to prevent blood clotting in the blood circuit during hemodialysis
and heparin is the most used blood thinner. However, heparin comes with a set
of side effects and certain risks.
However, FDA has
approved a new system that aims to prevent blood clotting without the use of
blood thinner medications in dialysis patients. The system is a polymer that
offers surface-modifying molecules that can be incorporated into the fiber
membrane of dialyzer. This system enables the elimination of the use of heparin
which could help reduce the risk of excessive bleeding from anticoagulants and
help eliminate risks associated with the use of blood thinner.
Apart from this,
several companies in the dialysis concentrate industry have invested in making
dialysis devices that can be operated at home, eliminating frequent visits to
hospitals. With the adoption of advanced devices and advancements in technology,
the lives of patients with kidney disorders can certainly be much easier and
hassle-free.
0 Comments